The chemist and druggist [electronic resource] . an level of fees and thebalance betweenindustry and theCommission is still underdiscussion. The decision to locatethe EMEA in London hasbeen widely supportedby the pharmaceuticalindustry worldwide. Asurvey of top UK,Continental and USdrugs companies showedan overwhelmingpreference for London:four times as manyexecutives supportedLondon compared to any of theother six countries hoping tohouse the Agency. The London location willattract many overseascompanies which are expectedto set up registration offices inor around London to be
The chemist and druggist [electronic resource] . an level of fees and thebalance betweenindustry and theCommission is still underdiscussion. The decision to locatethe EMEA in London hasbeen widely supportedby the pharmaceuticalindustry worldwide. Asurvey of top UK,Continental and USdrugs companies showedan overwhelmingpreference for London:four times as manyexecutives supportedLondon compared to any of theother six countries hoping tohouse the Agency. The London location willattract many overseascompanies which are expectedto set up registration offices inor around London to be nearthe new Agency. Severalthousand new jobs could becreated in the London area as aresult. During the lobbyingcampaign, Mrs Bottomelystated: A successful EuropeanMedicines Evaluation Agencywill benefit all the people ofEurope. It will help to makemedicines safe and will help tostrengthen the importantEuropean pharmaceuticalindustry. The British pharmaceuticalindustry is confident that thiswill happen. 166 Chemist & Druggist 29 JANUARY 1994.
Size: 2236px × 1118px
Photo credit: © The Reading Room / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: ., bookcentury1800, bookdecade185, booksubjectpharmacy, bookyear1859
